Come up with a name for your new list and we'll add to it:
CUTISS raised a round of funding on May 18, 2017. Investors include
W.A. de Vigier Stiftung.
CUTISS developed the denovoSkin, a personalized bioengineered skin graft product for the treatment of a broad spectrum of skin defects.…